BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28238765)

  • 1. Cytoplasmic versus periplasmic expression of site-specifically and bioorthogonally functionalized nanobodies using expressed protein ligation.
    Billen B; Vincke C; Hansen R; Devoogdt N; Muyldermans S; Adriaensens P; Guedens W
    Protein Expr Purif; 2017 May; 133():25-34. PubMed ID: 28238765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
    Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
    Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-Selective Functionalization of Nanobodies Using Intein-Mediated Protein Ligation for Innovative Bioconjugation.
    Graulus GJ; Ta DT; Tran H; Hansen R; Billen B; Royackers E; Noben JP; Devoogdt N; Muyldermans S; Guedens W; Adriaensens P
    Methods Mol Biol; 2019; 2033():117-130. PubMed ID: 31332751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving the yield of recalcitrant Nanobodies® by simple modifications to the standard protocol.
    Kariuki CK; Magez S
    Protein Expr Purif; 2021 Sep; 185():105906. PubMed ID: 33991675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of folding factors in rescuing unstable heterologous lipase B to enhance its overexpression in the periplasm of Escherichia coli.
    Xu Y; Lewis D; Chou CP
    Appl Microbiol Biotechnol; 2008 Jul; 79(6):1035-44. PubMed ID: 18496685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic Production of Nanobodies and Nanobody-Based Reagents by Co-Expression of Sulfhydryl Oxidase and DsbC Isomerase.
    de Marco A
    Methods Mol Biol; 2022; 2446():145-157. PubMed ID: 35157272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved production of single domain antibodies with two disulfide bonds by co-expression of chaperone proteins in the Escherichia coli periplasm.
    Shriver-Lake LC; Goldman ER; Zabetakis D; Anderson GP
    J Immunol Methods; 2017 Apr; 443():64-67. PubMed ID: 28131818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli.
    Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y
    J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of Disulfide-Bonded Proteins in Escherichia coli.
    Ke N; Berkmen M
    Curr Protoc Mol Biol; 2014 Oct; 108():16.1B.1-16.1B.21. PubMed ID: 25271713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential closure of the cytoplasm and then the periplasm during cell division in Escherichia coli.
    Skoog K; Söderström B; Widengren J; von Heijne G; Daley DO
    J Bacteriol; 2012 Feb; 194(3):584-6. PubMed ID: 22101847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High yield purification of nanobodies from the periplasm of E. coli as fusions with the maltose binding protein.
    Salema V; Fernández LÁ
    Protein Expr Purif; 2013 Sep; 91(1):42-8. PubMed ID: 23856605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of variable domain orientation on anti-HER2 single-chain variable fragment antibody expressed in the Escherichia coli cytoplasm.
    Koçer İ; Cox EC; DeLisa MP; Çelik E
    Biotechnol Prog; 2021 Mar; 37(2):e3102. PubMed ID: 33190426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the human hepcidin gene to build a positive-selection vector for periplasmic expression in Escherichia coli.
    Haustant J; Sil A; Maillo-Rius C; Hocquellet A; Costaglioli P; Garbay B; Dieryck W
    Anal Biochem; 2016 May; 500():35-7. PubMed ID: 26873403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbial host selection and periplasmic folding in Escherichia coli affect the biochemical characteristics of a cutinase from Fusarium oxysporum.
    Nikolaivits E; Kokkinou A; Karpusas M; Topakas E
    Protein Expr Purif; 2016 Nov; 127():1-7. PubMed ID: 27302766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuned Escherichia coli as a host for the expression of disulfide-rich proteins.
    Salinas G; Pellizza L; Margenat M; Fló M; Fernández C
    Biotechnol J; 2011 Jun; 6(6):686-99. PubMed ID: 21567960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of the amicyanin signal sequence for efficient periplasmic expression in E. coli of a human antibody light chain variable domain.
    Dow BA; Tatulian SA; Davidson VL
    Protein Expr Purif; 2015 Apr; 108():9-12. PubMed ID: 25573388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of bioactive chicken follistatin315 in Escherichia coli.
    Lee SB; Choi R; Park SK; Kim YS
    Appl Microbiol Biotechnol; 2014 Dec; 98(24):10041-51. PubMed ID: 25411099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
    Noor A; Walser G; Wesseling M; Giron P; Laffra AM; Haddouchi F; De Grève J; Kronenberger P
    BMC Res Notes; 2018 Oct; 11(1):751. PubMed ID: 30348204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Biosensor Platforms for Detecting the Atherosclerotic Biomarker VCAM1 Based on Bioconjugation with Uniformly Oriented VCAM1-Targeting Nanobodies.
    Ta DT; Guedens W; Vranken T; Vanschoenbeek K; Steen Redeker E; Michiels L; Adriaensens P
    Biosensors (Basel); 2016 Jul; 6(3):. PubMed ID: 27399790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.